HeyJaredRandy E. Miller
- Indexed articles, last 90 days
- 2
- Latest publication
- Sep 24, 2026
- Outlet visibility, for Lawstreetmedia
- Top 50M sites
- Earliest in this view
- Aug 20, 2026
Latest articles
A Hedge Fund Rolls the Dice on Ultragenyx | Law Street Media (opens the original)
Read excerpt
FOIAengine: Sofinnova Bet on Drug FDA Approved Last Week Shares of Ultragenyx Pharmaceutical Inc. rose 16 percent September 17 after the Food and Drug Administration approved Fayuvi, its gene therapy for Sanfilippo syndrome Type A, a rare and devastating genetic disease that strikes children and progressively damages the brain and nervous system. Investment firm Sofinnova Investments, holder of a significant stake in Ultragenyx, was on the alert for Thursday’s FDA decision. Ahead of that, the in
How Reporters Used FOIA to Cover Cyclospora Outbreak | Law Street Media (opens the original)
Read excerpt
FOIAengine: Twenty-One Requests from News Media, Non-Profits and Companies The nationwide outbreak of cyclospora infections this summer prompted a steady stream of national and local news articles, along with 21 Freedom of Information Act requests to the Food and Drug Administration. These requests, which have not previously been reported, were submitted by the news media (13), non-profit organizations (6), and commercial organizations (2). The FDA, the Centers for Disease Control, and state and
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 50M sites
For Lawstreetmedia, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.